Mercados españoles cerrados

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Precio en tiempo real. Divisa en USD
Añadir a la lista de favoritos
158,95-8,57 (-5,12%)
A partir del 03:06PM EST. Mercado abierto.

Moderna, Inc.

200 Technology Square
Cambridge, MA 02139
United States
617 714 6500
https://www.modernatx.com

Sector(es)Healthcare
SectorBiotechnology
Empleados a tiempo completo1300

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Dr. Noubar B. Afeyan Ph.D.Co-Founder, Independent Non Exec. Chairman & Member of Technology Advisory Board107,5kN/A1963
Mr. Stephane BancelCEO & Director3,86MN/A1973
Dr. Stephen HogePres1,26M19,56M1976
Mr. David W. MelineCFO & Principal Accounting Officer932,62kN/A1957
Mr. Juan AndresChief Technical Operations & Quality Officer1,25M9,32M1965
Dr. John V. W. ReyndersChief Information OfficerN/AN/AN/A
Dr. Melissa J. Moore Ph.D.Chief Scientific Officer & Member of Scientific Advisory BoardN/AN/AN/A
Ms. Lavina Talukdar CFASr. VP & Head of Investor RelationsN/AN/AN/A
Ms. Shannon Thyme KlingerChief Legal Officer & Corp. Sec.N/AN/A1971
Colleen HusseySr. Mang. of Corp. CommunicationsN/AN/AN/A
Los importes son a partir de 31 de diciembre de 2020 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted and cell surface therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, the Biomedical Advanced Research and Development Authority, the Defense Advanced Research Projects Agency, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, the Coalition for Epidemic Preparedness Innovations, Metagenomi, Inc., and Bill & Melinda Gates Foundation. Moderna, Inc. also has collaborations with Lonza Ltd.; Catalent Inc., Laboratorios Farmacéuticos Rovi, S.A., Recipharm, and Lonza Group; Aldevron, LLC; Institute for Life Changing Medicines; and AbCellera Biologics Inc. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Gobierno corporativo

El ISS Governance QualityScore de Moderna, Inc., a día 26 de septiembre de 2021, es 10. Las puntuaciones base son Auditoría: 7; Tablero: 10; Derechos de los accionistas: 10; Compensación: 9.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.